Background illustration for clinical trials search

Paid Clinical Trials Louisville

Discover 503 paid clinical trials in Louisville, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Louisville KY, Ann Arbor MI, Philadelphia PA,
Sponsor: OncoC4, Inc.

Sex: All

Age: 18+

Code: NCT06352359

Phase 1, Recruiting

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

for
Breast Cancer
Location: Louisville KY, Edgewood KY, Newburgh IN, Kingsport TN,
Sponsor: Exact Sciences Corporation

Sex: All

Age: 18+

Code: NCT06401421

Recruiting

A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma

for
Glioma
Location: Louisville KY
Sponsor: Kentuckiana Cancer Institute

Sex: All

Age: 18 - 70+

Code: NCT00660621

Phase 2, Recruiting

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

for
Advanced Cancer
Location: Louisville KY, Nashville TN, Fairfax VA, Bethesda MD,
Sponsor: Riboscience, LLC.

Sex: All

Age: 18+

Code: NCT05270213

Phase 1, Recruiting

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Louisville KY, Columbus OH, Atlanta GA, New York NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03761108

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Louisville KY, Cincinnati OH, Nashville TN,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase 3, Recruiting

A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Louisville KY, Columbus OH, Charlotte NC, Milwaukee WI,
Sponsor: Regeneron Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT05125016

Phase 1, Phase 2, Recruiting

A Study of ASP1002 in Adults for Treatment of Solid Tumors

for
Advanced Solid Tumors
Location: Louisville KY, Cleveland OH, Detroit MI, Iowa City IA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT05719558

Phase 1, Recruiting

The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Louisville KY, Atlanta GA, Fairway KS, Dallas TX,
Sponsor: Impact Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04768868

Phase 1, Recruiting

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

for
Metastatic Breast Cancer
Location: Louisville KY, Columbus OH, St Louis MO, Cleveland OH,
Sponsor: LeonaBio

Sex: All

Age: 18+

Code: NCT05696626

Phase 3, Recruiting

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

for
Advanced Solid Malignancies
Location: Louisville KY, Nashville TN, Richmond VA,
Sponsor: Georgiamune Inc

Sex: All

Age: 18+

Code: NCT06028074

Phase 1, Phase 2, Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Louisville KY, Cincinnati OH, Nashville TN, Columbus OH,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05552222

Phase 3, Recruiting

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Louisville KY, Cincinnati OH, Indianapolis IN,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female

Age: 18+

Code: NCT05128825

Phase 2, Recruiting

Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer

for
C-Met Exon 14 Mutation
Location: Louisville KY
Sponsor: Haihe Biopharma Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT04270591

Phase 1, Phase 2, Recruiting

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

for
B-cell Non-Hodgkins Lymphoma (B-NHL)
Location: Louisville KY, New Brunswick NJ, New York NY, Dallas TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05685173

Phase 1, Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Louisville KY, Lexington KY, Cincinnati OH,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase 2, Recruiting

Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Louisville KY, St Louis MO, Chicago IL, Detroit MI,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06295731

Phase 2, Phase 3, Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: Louisville KY, Edgewood KY, Cincinnati OH, Knoxville TN,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase 3, Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Louisville KY, Detroit MI, Milwaukee WI, Iowa City IA,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT04198766

Phase 1, Phase 2, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Louisville KY, Cincinnati OH, Indianapolis IN,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase 3, Recruiting